medRxivGenetic & Genomic MedicinePreprint
Atlas of glomerular disease-specific genetic effects on blood transcriptome
Lili LiuiD, C H Wang, Oleksandr Kravets, Damian FerminiD, Felix H. EichingeriD, Francesca ZanoniiD, Atlas KhaniD, Jun Y. ZhangiD, Yan OuyangiD, Qin LiiD, Patrick HamiltoniD, Philip A. KalraiD, Rajkumar ChinnaduraiiD, Kimberly J. ReidyiD, Jeffrey B. KoppiD, Krzysztof MuchaiD, Cathy SmithiD, Abigail Smith, Michelle McNulty, Sean F. EddyiD, Viji NairiD, Margaret E. HelmuthiD, Tetyana Vasylyeva, William E. SmoyeriD, Céline C. BerthieriD, , Krzysztof KirylukiD
Abstract
IgA nephropathy (IgAN), IgA vasculitis (IgAV), focal segmental glomerulosclerosis (FSGS), membranous nephropathy (MN), and minimal change disease (MCD) account for the majority of idiopathic glomerulo-nephropathies (GN). These disorders involve immune system dysregulation and have a complex genetic architecture. Currently, there are no adequately powered blood transcriptomic datasets coupled to genetic data from patients with GN that can delineate disease-context specific genetic effects on the blood immune cell transcriptome. We performed whole genome sequencing coupled with bulk blood transcriptome sequencing on 1,822 participants from the CureGN study, a prospective cohort of participants with a kidney biopsy diagnosis of primary GN. We generated disease-context specific transcriptome-wide maps of gene expression QTL (eQTL), splicing QTL (sQTL), and double strand RNA-editing QTL (edQTL) for FSGS (N=447), IgAN (N=403), IgAV (N=123), MCD (N=408), and MN (N=441), as well as cross-disease maps for all 1,822 participants. Our QTL mapping identified 16,068 eGenes, 4,644 sGenes and 4,611 edQTLs with an FDR<0.05 in at least one GN type. Approximately 5-10% of the QTL signals were unique to a specific GN type, while [~]90% were shared between at least two conditions. Colocalization analysis demonstrated that [~]80% of shared eGenes between traits also shared the same causal variants, whereas [~]2% had distinct causal variants, suggesting context-specific regulatory effects. Cross-phenotype QTL mapping uncovered 6,466 eGenes, 2,705 sGenes and 5,321 edQTLs not previously detected in GTEx. Age, eGFR, and proteinuria-interaction QTL analyses identified hundreds of loci modified by age or disease severity. Lastly, integrative analyses with GWAS nominated new candidate genes for each of the five GN types under study. In summary, we generated comprehensive maps of GN-context-specific genetic effects on the blood transcriptome, providing a powerful new resource for integrative gene discovery studies of primary GN.
- organism: human
- assay: bulk RNA-seq
- research focus: gene regulatory network inference
- approach: statistical model
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- An eQTL landscape of kidney tissue in human nephrotic syndrome
Christopher E. Gillies, Rosemary K.B. Putler, … Cindy Roy·The American Journal of Human GeneticsPeer-reviewed·Jul 26, 2018
- Identifying Therapeutic Strategies in IgA Nephropathy through Comprehensive Transcriptomic Characterization
Kenneth Ofori, Amin Yakubu, Alex J. Rai·bioRxiv·Aug 18, 2021
- GWAS defines pathogenic signaling pathways and prioritizes drug targets for IgA nephropathy
Krzysztof Kiryluk, Elena Sánchez, … Claudia Izzi·medRxiv·Nov 19, 2021
- Inflammatory molecules in the glomerular endothelium in mild IgA-Nephropathy identified by single-cell and spatial transcriptome
Kumi Hasegawa, Nagako Kawashima, … Shokichi Naito·bioRxiv·Oct 30, 2024
- Inflammatory and JAK-STAT Pathways as Shared Molecular Targets for ANCA-Associated Vasculitis and Nephrotic Syndrome
Sean F. Eddy, Viji Nair, … Matthias Kretzler·bioRxiv·Sep 27, 2018
- ANALYSIS OF GLOMERULAR TRANSCRIPTOMES FROM NEPHROTIC PATIENTS SUGGEST APOL1 RISK VARIANTS IMPACT PARIETAL EPITHELIAL CELLS
Agustin Gonzalez‐Vicente, Dana C. Crawford, … Nephrotic Syndrome Study Network·medRxiv·Nov 5, 2024